These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19913860)

  • 41. Macromolecular drug transport into the brain using targeted therapy.
    Lichota J; Skjørringe T; Thomsen LB; Moos T
    J Neurochem; 2010 Apr; 113(1):1-13. PubMed ID: 20015155
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of CNS transporters in the pharmacotherapy of HIV-1 associated neurological disorders.
    Ashraf T; Robillard K; Chan GN; Bendayan R
    Curr Pharm Des; 2014; 20(10):1543-63. PubMed ID: 23789949
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Confocal imaging of xenobiotic transport across the blood-brain barrier.
    Miller DS
    J Exp Zool A Comp Exp Biol; 2003 Nov; 300(1):84-90. PubMed ID: 14598390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Specific AHNAK expression in brain endothelial cells with barrier properties.
    Gentil BJ; Benaud C; Delphin C; Remy C; Berezowski V; Cecchelli R; Feraud O; Vittet D; Baudier J
    J Cell Physiol; 2005 May; 203(2):362-71. PubMed ID: 15493012
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Possible involvement of gap junctions in the barrier function of tight junctions of brain and lung endothelial cells.
    Nagasawa K; Chiba H; Fujita H; Kojima T; Saito T; Endo T; Sawada N
    J Cell Physiol; 2006 Jul; 208(1):123-32. PubMed ID: 16547974
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences.
    Redzic Z
    Fluids Barriers CNS; 2011 Jan; 8(1):3. PubMed ID: 21349151
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The blood-brain interface.
    Bradbury MW; Lightman SL
    Eye (Lond); 1990; 4 ( Pt 2)():249-54. PubMed ID: 2199234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immune surveillance of the human central nervous system (CNS): different migration pathways of immune cells through the blood-brain barrier and blood-cerebrospinal fluid barrier in healthy persons.
    Kleine TO; Benes L
    Cytometry A; 2006 Mar; 69(3):147-51. PubMed ID: 16479603
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efflux transporters in the blood-brain interfaces--in vitro and in vivo methods and correlations.
    Krajcsi P; Jani M; Tóth B; Erdo F; Kis E; Beéry E; Sziráki I
    Expert Opin Drug Metab Toxicol; 2012 Apr; 8(4):419-31. PubMed ID: 22394316
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The impact of glia-derived extracellular matrices on the barrier function of cerebral endothelial cells: an in vitro study.
    Hartmann C; Zozulya A; Wegener J; Galla HJ
    Exp Cell Res; 2007 Apr; 313(7):1318-25. PubMed ID: 17346702
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is the pial microvessel a good model for blood-brain barrier studies?
    Allt G; Lawrenson JG
    Brain Res Brain Res Rev; 1997 Jun; 24(1):67-76. PubMed ID: 9233542
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Regulation of brain microvessel function].
    Kobayashi H; Yokoo H; Yanagita T; Wada A
    Nihon Yakurigaku Zasshi; 2002 May; 119(5):281-6, 309. PubMed ID: 12061139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The blood-brain barrier: its role in contrast studies.
    Kirkpatrick JB
    Comput Tomogr; 1978; 2(3):189-96. PubMed ID: 710090
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Choroid plexus controls brain availability of anti-HIV nucleoside analogs via pharmacologically inhibitable organic anion transporters.
    Strazielle N; Belin MF; Ghersi-Egea JF
    AIDS; 2003 Jul; 17(10):1473-85. PubMed ID: 12824785
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Implication of the blood-brain barrier in neurological diseases: part II].
    Weiss N; Miller F; Cazaubon S; Couraud PO
    Rev Neurol (Paris); 2009 Dec; 165(12):1010-22. PubMed ID: 19487004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The development of the human blood-brain and blood-CSF barriers.
    Møllgård K; Saunders NR
    Neuropathol Appl Neurobiol; 1986; 12(4):337-58. PubMed ID: 3534622
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Blood-brain barrier part III: therapeutic approaches to cross the blood-brain barrier and target the brain].
    Weiss N; Miller F; Cazaubon S; Couraud PO
    Rev Neurol (Paris); 2010 Mar; 166(3):284-8. PubMed ID: 19699499
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isolation and culture of human brain microvessel endothelial cells for the study of blood-brain barrier properties in vitro.
    Biegel D; Spencer DD; Pachter JS
    Brain Res; 1995 Sep; 692(1-2):183-9. PubMed ID: 8548302
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood-brain barrier.
    Hladky SB; Barrand MA
    Fluids Barriers CNS; 2018 Oct; 15(1):30. PubMed ID: 30340614
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Transport of drugs across the blood-brain barrier].
    Breimer DD
    Verh K Acad Geneeskd Belg; 1998; 60(1):47-60; discussion 60-1. PubMed ID: 9646722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.